基于常规临床指标的慢性鼻窦炎伴鼻息肉无监督聚类分析及其治疗结局意义
本研究回顾性纳入2009至2017年因药物难治性双侧慢性鼻窦炎伴鼻息肉接受内镜鼻窦手术的375例患者,采用年龄、外周血嗜酸性粒细胞、组织嗜酸性粒细胞、Lund-Mackay CT评分、筛窦/上颌窦CT评分比(E/M比)及合并哮喘等常规临床指标进行无监督聚类分析,共识别出2个哮喘相关聚类和4个非哮喘相关聚类,各聚类4年免于修正手术率存在统计学显著差异(log-rank p < 0.05)。
要点
- 常规临床指标无监督聚类可将CRSwNP分为2个哮喘聚类与4个非哮喘聚类。
- 6个聚类4年免于修正手术率分别为100%、80.3%、98.0%、66.7%、100%、66.7%。
- 聚类间4年免于修正手术率差异有统计学意义(log-rank p < 0.05)。
核心结论
- 无监督聚类分析在CRSwNP中识别出2个哮喘相关聚类和4个非哮喘相关聚类,各聚类对应不同的临床结局。
研究设计与样本
- 回顾性研究,纳入2009至2017年因药物难治性双侧CRSwNP接受内镜鼻窦手术的患者,共375例数据可用。
- 采用年龄、外周血嗜酸性粒细胞、组织嗜酸性粒细胞、Lund-Mackay CT评分、E/M比及合并哮喘进行无监督聚类分析。
- 采用树分析开发聚类算法,采用Kaplan-Meier生存分析确定各聚类对应的免于修正手术概率。
主要发现
- 患者被分为6个聚类:2个哮喘聚类(A1:哮喘非嗜酸性息肉;A2:哮喘嗜酸性息肉)。
- 4个非哮喘聚类为:NA1(非嗜酸性息肉伴年龄较大)、NA2(非嗜酸性息肉伴年龄较轻)、NA3(嗜酸性息肉伴较低E/M比)、NA4(嗜酸性息肉伴较高E/M比)。
- 4年免于修正手术率:NA1为100%,NA2为80.3%,NA3为98.0%,NA4为66.7%,A1为100%,A2为66.7%。
- 各聚类4年免于修正手术率差异有统计学意义(log-rank p < 0.05)。
关键数值与推荐
- E/M比为筛窦与上颌窦CT评分之比,用于区分非哮喘嗜酸性息肉聚类NA3与NA4。
- 4年免于修正手术率最低为66.7%(NA4与A2),最高为100%(NA1与A1)。
临床怎么用
- 可基于年龄、血嗜酸性粒细胞、组织嗜酸性粒细胞、Lund-Mackay CT评分、E/M比和哮喘状态对CRSwNP患者进行聚类分型。
- 聚类分型有助于预判内镜鼻窦手术后修正手术风险,辅助个体化治疗决策。
局限性
- 为单中心回顾性研究,样本来自2009至2017年接受手术的药物难治性双侧CRSwNP患者。
- 聚类算法基于树分析开发,尚未在独立队列中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a multidimensional disease. In this study, we performed an unsupervised cluster analysis of CRSwNP using routinely available clinical markers. METHODS: We conducted a retrospective review of patients treated with endoscopic sinus surgery due to medically intractable bilateral CRSwNP from 2009 to 2017. Unsupervised cluster analysis was performed using a patient's clinical features, including age, peripheral blood eosinophil, tissue eosinophilia, Lund-Mackay computed tomography (CT) scores, ratio of the CT scores for the ethmoid sinus and maxillary sinus (E/M ratio), and comorbid asthma. Tree analysis was performed to develop a clustering algorithm. Kaplan-Meier survival analysis was performed to determine the revision surgery-free probability corresponding to each cluster. RESULTS: Data were available on 375 patients. Patients were categorized into 6 clusters comprising 2 asthmatic clusters and 4 non-asthmatic clusters. The labels for the 2 asthmatic clusters were: asthmatic non-eosinophilic polyp (cluster A1) and asthmatic eosinophilic polyp (cluster A2). The labels for the 4 non-asthmatic clusters were: non-eosinophilic polyp with older age (cluster NA1); non-eosinophilic pol'yp with younger age (cluster NA2); eosinophilic polyp with lower E/M ratio (cluster NA3); and eosinophilic polyp with higher E/M ratio (cluster NA4). The 4-year revision-free rates were 100% (cluster NA1), 80.3% (NA2), 98.0% (NA3), 66.7% (NA4), 100% (A1), and 66.7% (A2). The clusters showed statistically significant differences in terms of 4-year revision-free rates (log-rank p < 0.05). CONCLUSION: Cluster analysis identified 2 asthmatic clusters and 4 non-asthmatic clusters in CRSwNP. Each cluster corresponded to a different clinical outcome.
引用
- Kim JW, Huh G, Rhee CS, et al. Unsupervised cluster analysis of chronic rhinosinusitis with nasal polyp using routinely available clinical markers and its implication in treatment outcomes. Int Forum Allergy Rhinol. 2018. PMID: 30281956. doi:10.1002/alr.22221
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。